ADIM
GWPH

Alpha DNA Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Alpha DNA Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3
Closed – – 749
2021
Q1 		$0 Hold
3
– – ﹤0.01% 822
2020
Q4 		$0 Buy
+3
New +$336 ﹤0.01% 643

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Alpha DNA Investment Management's GWPH Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 3 shares.

Alpha DNA Investment Management first reported a position in GWPH in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021.
  • Alpha DNA Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $0 in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.